What are the typical symptoms and recommended management strategies for aortic stenosis?

Aortic Stenosis: Symptoms and Management

Classic Symptoms

The three cardinal symptoms of severe aortic stenosis are angina, exertional syncope, and heart failure—once any of these develop, survival drops dramatically to 2-3 years without intervention. 1 These symptoms indicate an urgent need for valve replacement. 1

• Angina occurs even without coronary disease due to increased myocardial oxygen demand from left ventricular hypertrophy 2
• Exertional syncope results from inability to increase cardiac output during exercise 3
• Heart failure symptoms (dyspnea, orthopnea, paroxysmal nocturnal dyspnea) develop when compensatory mechanisms fail 1, 4

Critical Pitfall: Asymptomatic Patients

Many patients with severe aortic stenosis subconsciously curtail their activities to avoid symptoms, falsely appearing asymptomatic. 2 A carefully monitored exercise stress test should be performed to confirm truly asymptomatic status and assess hemodynamic response. 1, 2

Diagnostic Evaluation

Doppler echocardiography is the cornerstone diagnostic test, sufficient to guide management in 65-70% of patients. 1

Severe Aortic Stenosis Criteria:

• Aortic valve area (AVA) <1.0 cm² 1
• Mean gradient ≥40 mmHg 1
• Peak velocity ≥4.0 m/s 1

Additional Testing When Needed:

• Multimodality imaging (cardiac CT, cardiac MRI, dobutamine stress echo) is required in 25-30% of patients when echocardiography findings are discordant or uncertain 1
• Exercise stress testing for apparently asymptomatic patients to unmask symptoms and assess hemodynamic response 1, 2
• Coronary angiography before valve surgery in men >40 years, postmenopausal women, or those with cardiovascular risk factors 1

Management Strategy

Symptomatic Severe Aortic Stenosis

Intervention is mandatory in all symptomatic patients with severe aortic stenosis—this is a Class I indication. 1 Medical management alone is not indicated and leads to rapid mortality. 1

Choice of Intervention:

Surgical aortic valve replacement (SAVR) is recommended for patients at low surgical risk (STS or EuroSCORE II <4%). 1

Transcatheter aortic valve implantation (TAVI) is recommended for:

• Patients unsuitable for SAVR (prohibitive surgical risk) 1
• Patients at increased surgical risk (STS or EuroSCORE II ≥4%), particularly elderly patients suitable for transfemoral access 1

All decisions must be made by a multidisciplinary Heart Team at a center with both cardiology and cardiac surgery departments on-site. 1

Asymptomatic Severe Aortic Stenosis

Intervention is indicated in asymptomatic patients with:

• Left ventricular ejection fraction (LVEF) <50% not due to another cause 1
• Abnormal exercise test showing symptoms clearly related to aortic stenosis 1
• Very severe aortic stenosis (AVA ≤0.6 cm², mean gradient ≥50 mmHg, or peak velocity ≥5.0 m/s) may warrant earlier intervention 1

For truly asymptomatic patients with preserved LVEF, watchful waiting with close surveillance is appropriate. 2, 4

Surveillance Intervals for Asymptomatic Patients:

Serial Doppler echocardiography frequency: 4

• Severe AS: Every 6-12 months
• Moderate AS: Every 1-2 years
• Mild AS: Every 3-5 years

Special Situations

Low-flow, low-gradient aortic stenosis with reduced ejection fraction: Intervention is indicated if dobutamine stress echo demonstrates contractile reserve and confirms true severe stenosis (excluding pseudosevere AS). 1

Patients refusing or unsuitable for valve replacement: Noncardiac surgery carries approximately 10% mortality risk. 1 Percutaneous balloon aortic valvuloplasty may serve as a bridge to definitive therapy in hemodynamically unstable patients. 1

Medical Management Considerations

There is no effective pharmacologic treatment to prevent progression or treat severe symptomatic aortic stenosis. 1, 5

Avoid in symptomatic severe AS: 1

• Diuretics (can reduce preload critically)
• Vasodilators (risk of hypotension)
• Beta-adrenergic agonists (may worsen obstruction)

Hemodynamic management principles: 3

• Maintain adequate preload (critical for cardiac output)
• Control heart rate (both bradycardia and tachycardia cause decompensation)
• Use vasopressors at lowest effective dose if hypotensive
• Nitrates may be reasonable for hypertension with heart failure symptoms, but avoid hypotension 3

Key Pitfall: Perioperative Risk

Severe aortic stenosis poses the greatest risk for noncardiac surgery. 1 If symptomatic, elective noncardiac surgery should be postponed or canceled until after aortic valve replacement. 1 If asymptomatic but not evaluated within one year, surgery should be postponed for valve assessment. 1

Intervention should not be performed in patients with severe comorbidities when unlikely to improve quality of life or survival. 1